Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential

Drug Testing and Analysis

Volumn 4, Issue 9, 2012, Pages 733-738

  Esposito, Simone ^a   Deventer, Koen ^a   Goeman, Jan ^a   Van der Eycken, Johan ^a   Van Eenoo, Peter ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Doping; LC MS; TB 500; Thymosin

Indexed keywords

MASS SPECTROMETRY; SYNTHESIS (CHEMICAL);

AS DOPING; DOPING AGENT; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; LC-MS; LIQUID CHROMATOGRAPHY-HIGH RESOLUTION MASS SPECTROMETRIES; N-TERMINALS; ORBITRAP; SYNTHESIS AND CHARACTERIZATIONS; TB-500; THYMOSIN;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

PERFORMANCE ENHANCING SUBSTANCE; TB 500; THYMOSIN BETA4; UNCLASSIFIED DRUG;

ACETYLATION; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANGIOGENESIS; APOPTOSIS; CELL SURVIVAL; DOPING; DRUG FORMULATION; DRUG MISUSE; DRUG SYNTHESIS; IMMUNE SYSTEM; LETTER; MOLECULAR WEIGHT; MUSCLE GROWTH; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TISSUE REGENERATION; TISSUE REPAIR;

EID: 84866770482     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1402     Document Type: Letter

References (16)

1. WADA. The 2012 Prohibited List International Standards. 2012. Available at: http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/2012/WADA_Prohibited_List_2012_EN.pdf [20 July 2012].
2. A. Thomas, M. Kohler, J. Mester, H. Geyer, W. Schanzer, M. Petrou, et al. Identification of the growth-hormone-releasing peptide-2 (GHRP-2) in a nutritional supplement. Drug Test. Anal. 2010, 2, 144.
3. J. Henninge, M. Pepaj, I. Hullstein, P. Hemmersbach Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation. Drug Test. Anal. 2010, 2, 647.
4. M. Kohler, A. Thomas, K. Walpurgis, K. Terlouw, W. Schanzer, M. Thevis Detection of His-tagged Long-R-3-IGF-I in a black market product. Growth Horm. IGF Res. 2010, 20, 386.
5. S. Esposito Characterization and identification of a C-terminal amidated mechano growth factor (MGF) analogue in black market products. Rapid Comm. Mass Spectr. 2012, 26, 686.
6. F. Guan, C.E. Uboh, L.R. Soma, J. Rudy Sequence Elucidation of an Unknown Cyclic Peptide of High Doping Potential by ETD and CID Tandem Mass Spectrometry. J. Am. Soc. Mass Spectr. 2011, 22, 718.
7. T. Huff, C.S.G. Muller, A.M. Otto, R. Netzker, E. Hannappel beta-thymosins, small acidic peptides with multiple functions. Int. J. Biochem. Cell Biol. 2001, 33, 205.
8. D. Philp, H.K. Kleinman Animal studies with thymosin beta(4), a multifunctional tissue repair and regeneration peptide. Thymosins in Health and Disease 2010, 1194, 81.
9. Cycling News. Vansevenant alleged to have imported doping products. Available at: http://www.cyclingnews.com/news/vansevenant-alleged-to-have-imported-doping-products [20 July 2012].
10. Cycling News. Ten arrested for being allegedly implicated in a doping trafficking network. Available at: http://www.deltaworld.org/sport/Ten-arrested-for-being-allegedly-implicated-in-a-doping-trafficking-network/ [20 July 2012].
11. G.B. Fields, R.L. Noble Solid-phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int. J. Pept. Protein Res. 1990; 35, 161.
12. D.S. King, C.G. Fields, G.B. Fields A cleavage method which minimizes side reactions following Fmoc solid-phase peptide synthesis. Int. J. Pept. Prot. Res. 1990, 36, 255.
13. G. Sosne, P. Qiu, A.L. Goldstein, M. Wheater Biological activities of thymosin beta(4) defined by active sites in short peptide sequences. FASEB J. 2010, 24, 2144.
14. T.R.S. Kumar, K. Soppimath, S.K. Nachaegari Novel delivery technologies for protein and peptide therapeutics. Curr. Pharmaceut. Biotechnol. 2006, 7, 261.
15. A. Thomas, E. Solymos, W. Schaenzer, N. Baume, M. Saugy, F. Dellanna, et al. Determination of vasopressin and desmopressin in urine by means of liquid chromatography coupled to quadrupole time-of-flight mass spectrometry for doping control purposes. Anal. Chim. Acta 2011, 707, 107.
16. A. Thomas, S. Hoeppner, H. Geyer, W. Schaenzer, M. Petrou, D. Kwiatkowska, et al. Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry. Anal. Bioanal. Chem. 2011, 401, 507.